naturalX Health Ventures has 2 portfolio companies on record at Recent Funding. It is a corporate venture investor based in DE, founded in 2022. Its most recent investment on record is Aktiia's $42M Series B+ round in May 2025, alongside Verve Ventures, Translink Capital, redalpine and 5 others. By category, its portfolio leans toward Health and bio (2) and Data and analytics (1).

About naturalX Health Ventures

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

What naturalX Health Ventures invests in

• Health and bio · 2 · 100%
• Data and analytics · 1 · 50%
• Consumer and social · 1 · 50%

How naturalX Health Ventures invests

Share is of the 1 round on Recent Funding that name naturalX Health Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

naturalX Health Ventures portfolio companies

• AAktiia$42MSeries B+ · May 2025
• HHilobacker

Most frequent co-investors

• KKhosla Ventures1 shared round · last May 5, 2025
• TTranslink Capital1 shared round · last May 5, 2025
• WWellington Management1 shared round · last May 5, 2025
• Rredalpine1 shared round · last May 5, 2025
• EEarlybird VC1 shared round · last May 5, 2025
• VVerve Ventures1 shared round · last May 5, 2025
• KK Fund1 shared round · last May 5, 2025
• MMolten Ventures1 shared round · last May 5, 2025

Similar investors

• IIntuitive Ventures2 companies · 2 deals in 12 mo
• CCVS Health Ventures2 companies · 1 deal in 12 mo
• GGS Futures3 companies · 1 deal in 12 mo
• AAngelini Ventures4 companies · 3 deals in 12 mo
• LLifeArc Ventures1 company
• SSanofi Ventures5 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists naturalX Health Ventures, which is a subset of its real portfolio. API: /api/v1/investors/naturalx-health-ventures (get a free API key). More: the most active VC firms and new venture capital funds.